IP Library Patent Application 12127694
Patent Application
App. No. 12/127,694

POROUS KERATIN CONSTRUCTS, WOUND HEALING ASSEMBLIES AND METHODS USING THE SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/127,694
Abstract

A porous keratin construct for use in wound healing is disclosed. The porous keratin construct may be used standing alone or in combination with a synthetic foam backing layer. Either the porous keratin construct or the porous keratin construct and synthetic foam combination may be used in a wound therapy such as negative pressure wound therapy. An assembly for use in negative pressure wound therapy may comprise a porous keratin construct or porous keratin construct and synthetic foam combination, a wound drape to encapsulate the wound and the porous keratin construct or porous keratin construct and synthetic foam combination, and a vacuum source in fluid communication with the wound drape to apply a negative pressure to the area encapsulated by the wound drape

Claims (40)

1 . A bone defect or soft tissue wound healing assembly comprising:

a first porous keratin protein construct for positioning in a bone defect site or soft tissue wound bed;

a wound drape for encapsulating a bone defect site or soft tissue wound bed and the first porous keratin protein construct positioned therein; and

a vacuum in fluid communication with the wound drape for applying negative pressure to an area encapsulated by the wound drape.

2 . The assembly of claim 1 , wherein the first porous keratin protein construct comprises a keratin protein selected from the group consisting of S-sulfonated keratin protein, oxidized keratin protein and reduced keratin protein.

3 . The assembly of claim 2 , wherein the keratin protein is a keratin protein fraction.

4 . The assembly of claim 3 , wherein the keratin protein fraction is selected from the group consisting of intermediate filament protein, high sulfur protein and high glycine-tyrosine protein.

5 . The assembly of claim 4 , wherein the keratin protein fraction is intact.

6 . The assembly of claim 5 , wherein the keratin protein fraction is hydrolysed.

7 . The assembly of claim 1 , further comprising one or more supplemental porous keratin protein constructs layered on top of the first porous keratin protein construct.

8 . The assembly of claim 1 , wherein the first porous keratin protein construct comprises perforations.

9 . A bone defect or soft tissue wound healing assembly comprising:

a first porous keratin protein construct for positioning in a bone defect site or soft tissue wound bed, the first porous keratin protein construct comprising:

a first surface for contacting a bone defect site or soft tissue wound bed; and

a second surface opposite the first surface;

a first synthetic foam construct positioned on the second surface of the first porous keratin protein construct;

a wound drape for encapsulating a bone defect site or soft tissue wound bed, the first porous keratin protein construct and the synthetic foam construct; and

a vacuum in fluid communication with the wound drape for applying negative pressure to an area encapsulated by the wound drape.

10 . The assembly of claim 9 , wherein the keratin protein construct comprises keratin protein selected from the group consisting of S-sulfonated keratin protein, oxidized keratin protein and reduced keratin protein.

11 . The assembly of claim 10 , wherein the keratin protein is a keratin protein fraction.

12 . The assembly of claim 11 , wherein the keratin protein fraction is selected from the group consisting of intermediate filament protein, high sulfur protein and high glycine-tyrosine protein.

13 . The assembly of claim 12 , wherein the keratin protein fraction is intact.

14 . The assembly of claim 13 , wherein the keratin protein fraction is hydrolysed.

15 . The assembly of claim 9 further comprising one or more supplemental porous keratin protein constructs positioned between the first porous keratin protein construct and the first synthetic foam construct.

16 . The assembly of claim 9 , further comprising one or more supplemental synthetic foam construct positioned on top of the first synthetic foam construct.

17 . The assembly of claim 9 , wherein the first porous keratin protein construct comprises perforations.

18 . A method for treating bone defects or soft tissue wounds comprising:

(1) positioning a porous keratin protein construct in a soft tissue wound bed or bone defect site;

(2) encapsulating the porous keratin protein construct and soft tissue wound bed or bone defect site with a wound drape to create an encapsulated area; and

(3) applying negative pressure to the encapsulated area;

19 . The method of claim 18 , wherein the method further comprises between steps (1) and (2), positioning a synthetic foam construct on the porous keratin protein construct.

20 . The method of claim 18 , wherein the porous keratin protein construct comprises a plurality of porous keratin protein constructs stacked on top of one another.

21 . The method of claim 19 , wherein the porous keratin protein construct comprises a plurality of porous keratin protein constructs stacked on top of one another.

22 . The method of claim 19 , wherein the synthetic foam construct comprises a plurality of synthetic foam constructs stacked on top of one another.

23 . The method of claim 18 , wherein the porous keratin protein construct comprises keratin protein selected from the group consisting of S-sulfonated keratin protein, oxidized keratin protein, and reduced keratin protein.

24 . The method of claim 23 , wherein the keratin protein is a keratin protein fraction.

25 . The method of claim 24 , wherein the keratin protein fraction is selected from the group consisting of intermediate filament protein, high sulfur protein, and high glycine-tyrosine protein.

26 . The method of claim 25 , wherein the keratin protein fraction is intact.

27 . The method of claim 25 , wherein the keratin protein is hydrolysed.

28 . The method of claim 18 , wherein the porous keratin protein construct comprises perforations.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 18, 2025
From: KMS VENTURES, LLC
To: KERAPLAST TECHNOLOGIES, LLC
Reel/Frame 072298/0575 →
SECURITY AGREEMENT Recorded Jun 4, 2010
From: KERAPLAST TECHNOLOGIES, LLC
To: KMS VENUTRES, INC.
Reel/Frame 024483/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2009
From: KERATEC LIMITED
To: KERAPLAST TECHNOLOGIES, LTD.
Reel/Frame 022328/0419 →